157 related articles for article (PubMed ID: 2347016)
1. Particle design of tolbutamide by the spherical crystallization technique. III. Micromeritic properties and dissolution rate of tolbutamide spherical agglomerates prepared by the quasi-emulsion solvent diffusion method and the solvent change method.
Sano A; Kuriki T; Kawashima Y; Takeuchi H; Hino T; Niwa T
Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):733-9. PubMed ID: 2347016
[TBL] [Abstract][Full Text] [Related]
2. Microstructures and pharmaceutical properties of ferulic acid agglomerates prepared by different spherical crystallization methods.
Chen H; Wang C; Kang H; Zhi B; Haynes CL; Aburub A; Sun CC
Int J Pharm; 2020 Jan; 574():118914. PubMed ID: 31811924
[TBL] [Abstract][Full Text] [Related]
3. Towards a better understanding of the role of stabilizers in QESD crystallizations.
Hansen J; Kleinebudde P
Pharm Res; 2022 Dec; 39(12):3123-3136. PubMed ID: 35266086
[TBL] [Abstract][Full Text] [Related]
4. Particle design of tolbutamide in the presence of soluble polymer or surfactant by the spherical crystallization technique: improvement of dissolution rate.
Sano A; Kuriki T; Handa T; Takeuchi H; Kawashima Y
J Pharm Sci; 1987 Jun; 76(6):471-4. PubMed ID: 3625493
[TBL] [Abstract][Full Text] [Related]
5. Spherical agglomeration to improve dissolution and micromeritic properties of an anticancer drug, Bicalutamide.
Dalvadi H; Parmar K; Yadav S
Drug Dev Ind Pharm; 2019 Jun; 45(6):968-980. PubMed ID: 30784326
[TBL] [Abstract][Full Text] [Related]
6. Agglomeration of celecoxib by quasi-emulsion solvent diffusion method without stabilizer: effect of good solvent.
Maghsoodi M; Nokhodchi A
Pharm Dev Technol; 2018 Dec; 23(10):1037-1046. PubMed ID: 27937049
[TBL] [Abstract][Full Text] [Related]
7. Definition of a solvent system for spherical crystallization of salbutamol sulfate by quasi-emulsion solvent diffusion (QESD) method.
Nocent M; Bertocchi L; Espitalier F; Baron M; Couarraze G
J Pharm Sci; 2001 Oct; 90(10):1620-7. PubMed ID: 11745720
[TBL] [Abstract][Full Text] [Related]
8. Improved compressibility, flowability, dissolution and bioavailability of pioglitazone hydrochloride by emulsion solvent diffusion with additives.
Patil SV; Pawar AP; Sahoo SK
Pharmazie; 2012 Mar; 67(3):215-23. PubMed ID: 22530302
[TBL] [Abstract][Full Text] [Related]
9. Agglomeration of Celecoxib by Quasi Emulsion Solvent Diffusion Method: Effect of Stabilizer.
Maghsoodi M; Nokhodchi A
Adv Pharm Bull; 2016 Dec; 6(4):607-616. PubMed ID: 28101468
[No Abstract] [Full Text] [Related]
10. Improving flowability and reducing storage agglomeration of metformin hydrochloride through QESD crystallization.
Hansen J; Kleinebudde P
Eur J Pharm Biopharm; 2021 Feb; 159():170-176. PubMed ID: 33460735
[TBL] [Abstract][Full Text] [Related]
11. Increasing the Batch Size of a QESD Crystallization by Using a MSMPR Crystallizer.
Hansen J; Kleinebudde P
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745799
[TBL] [Abstract][Full Text] [Related]
12. Spherical crystallization of drugs.
Kovačič B; Vrečer F; Planinšek O
Acta Pharm; 2012 Mar; 62(1):1-14. PubMed ID: 22472445
[TBL] [Abstract][Full Text] [Related]
13. Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies.
Muatlik S; Usha AN; Reddy MS; Ranjith AK; Pandey S
Pak J Pharm Sci; 2007 Jul; 20(3):218-26. PubMed ID: 17545107
[TBL] [Abstract][Full Text] [Related]
14. Enhancing Flowability of Lamivudine through Quasi-Emulsion Solvent-Diffusion (QESD) Crystallization: A Comprehensive Study on Surfactant Impact, Particle Morphology by QbD concepts and Tablet Compression Challenges.
Sreeharsha N; Gajula LR; S SK; Bhavani PD; Goudanavar P; A R; Naveen NR; Shiroorkar PN; Meravanige G; Telsang M; Asif AH; Sreenivasalu PKP
Eur J Pharm Sci; 2024 Jun; ():106835. PubMed ID: 38908413
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization.
Maghsoodi M; Tajalli Bakhsh AS
Pharm Dev Technol; 2011 Jun; 16(3):243-9. PubMed ID: 20175665
[TBL] [Abstract][Full Text] [Related]
16. Preparation, evaluation and need of spherical crystallization in case of high speed direct tabletting.
Pandey S; Patil AT
Curr Drug Deliv; 2014; 11(2):179-90. PubMed ID: 23848355
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the dissolution rate of a poorly water-soluble drug (tolbutamide) by a spray-drying solvent deposition method and disintegrants.
Takeuchi H; Handa T; Kawashima Y
J Pharm Pharmacol; 1987 Oct; 39(10):769-73. PubMed ID: 2891813
[TBL] [Abstract][Full Text] [Related]
18. Effect of process variables on physicomechanical properties of the agglomerates obtained by spherical crystallization technique.
Maghsoodi M
Pharm Dev Technol; 2011 Oct; 16(5):474-82. PubMed ID: 20557281
[TBL] [Abstract][Full Text] [Related]
19. Characterization of polymorphs of tranilast anhydrate and tranilast monohydrate when crystallized by two solvent change spherical crystallization techniques.
Kawashima Y; Niwa T; Takeuchi H; Hino T; Itoh Y; Furuyama S
J Pharm Sci; 1991 May; 80(5):472-8. PubMed ID: 1715401
[TBL] [Abstract][Full Text] [Related]
20. Enabling the direct compression of metformin hydrochloride through QESD crystallization.
Hansen J; Kleinebudde P
Int J Pharm; 2021 Aug; 605():120796. PubMed ID: 34119580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
